Optogenetic approaches to vision restoration
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Inherited retinal disease (IRD) affects about 1 in 3000 to 1 in 5000 individuals and is now believed to be the most common cause of blindness registration in developed countries. Until recently, the management of such conditions had been exclusively supportive. However, advances in molecular biology and medical engineering have now seen the rise of a variety of approaches to restore vision in patients with IRDs. Optogenetic approaches are primarily aimed at rendering secondary and tertiary neurons of the retina light‐sensitive in order to replace degenerate or dysfunctional photoreceptors. Such approaches are attractive because they provide a “causative gene‐independent” strategy, which may prove suitable for a variety of patients with IRD. We discuss theoretical and practical considerations in the selection of optogenetic molecules, vectors, surgical approaches and review previous trials of optogenetics for vision restoration. Optogenetic approaches to vision restoration have yielded promising results in pre‐clinical trials and a phase I/II clinical trial is currently underway (ClinicalTrials.gov NCT02556736). Despite the significant inroads made in recent years, the ideal optogenetic molecule, vector and surgical approach have yet to be established. HighlightsOptogenetic approaches to vision restoration seek to restore vision to patients with inherited retinal diseases by rendering secondary and tertiary neurones of the retina light‐sensitive.Two principal classes of molecule can be used: Type 1 (microbial) opsins or Type 2 (animal) opsins.Pre‐clinical trials of optogenetic approaches in animal models suggest that the technique may restore vision in previously blind animals, with the threshold for activation being within 1‐2 log units of the threshold for cone activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human photoreceptor topography
Curcio, C. A., Sloan, K. R., Kalina, R. E., & Hendrickson, A. E. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902920402 · Cited by 3,167
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
MacLaren, R. E., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Seymour, L., Clark, K. R., During, M. J., Cremers, F. P. M., Black, G. C. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62117-0 · Cited by 796
Dalkara, D., Byrne, L. C., Klimczak, R. R., Visel, M., Yin, L., Merigan, W. H., Flannery, J. G., & Schaffer, D. V. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005708 · Cited by 734
Selection and evaluation of clinically relevant AAV variants in a xenograft liver model
Lisowski, L., Dane, A. P., Chu, K., Zhang, Y., Cunningham, S. C., Wilson, E. M., Nygaard, S., Grompe, M., Alexander, I. E., & Kay, M. A. (2014) · Nature · doi:10.1038/nature12875 · Cited by 450
Self-citationSpectral transmission of the human ocular media
Norren, D. V., & Vos, J. J. (1974) · Vision Research · doi:10.1016/0042-6989(74)90222-3 · Cited by 377
da Cruz, L., Coley, B. F., Dorn, J., Merlini, F., Filley, E., Christopher, P., Chen, F. K., Wuyyuru, V., Sahel, J., Stanga, P., et al. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-301525 · Cited by 359
The Cone-specific visual cycle
Wang, J.-S., & Kefalov, V. J. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.11.001 · Cited by 335
Bailes, H. J., & Lucas, R. J. (2013) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2012.2987 · Cited by 319
Ahuja, A. K., Dorn, J. D., Caspi, A., McMahon, M. J., Dagnelie, G., daCruz, L., Stanga, P., Humayun, M. S., Greenberg, R. J., & Argus II Study Group (2011) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.179622 · Cited by 289
Research works printed but not linked: 62
- Aboshiha, 2014, Dark-adaptation functions in molecularly confirmed achromatopsia and the implications for assessment in retinal therapy trials, Invest. Ophthalmol. Vis. Sci., 55, 6340, 10.1167/iovs.14-14910 · DOI
- Ahnelt, 1998, The photoreceptor mosaic, Eye, 12, 531, 10.1038/eye.1998.142 · DOI
- Ahnelt, 2000, The mammalian photoreceptor mosaic-adaptive design, Prog. Retin. Eye Res., 19, 711, 10.1016/S1350-9462(00)00012-4 · DOI · Paper page
- Ait-Ali, 2015, Rod-derived cone viability factor promotes cone survival by stimulating aerobic glycolysis, Cell, 161, 817, 10.1016/j.cell.2015.03.023 · DOI · Paper page
- Ameline, 2017, Long-term expression of melanopsin and channelrhodopsin causes no gross alterations in the dystrophic dog retina, Gene Ther., 10.1038/gt.2017.63 · DOI
- Barlow, 1957, Purkinje shift and retinal noise, Nature, 179, 255, 10.1038/179255b0 · DOI
- Bi, 2006, Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration, Neuron, 50, 23, 10.1016/j.neuron.2006.02.026 · DOI · Paper page
- Bird, 1995, Retinal photoreceptor dystrophies LI. Edward Jackson Memorial lecture, Am. J. Ophthalmol., 119, 543, 10.1016/S0002-9394(14)70212-0 · DOI · Paper page
- Busskamp, 2010, Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa, Science, 329, 413, 10.1126/science.1190897 · DOI · Paper page
- Callaway, 2005, Structure and function of parallel pathways in the primate early visual system, J. Physiol., 566, 13, 10.1113/jphysiol.2005.088047 · DOI · Paper page
- Carroll, 1952, Congenital stationary night blindness without ophthalmoscopic or other abnormalities, Trans. Am. Ophthalmol. Soc., 50, 193
- Chaffiol, 2017, A new promoter allows optogenetic vision restoration with enhanced sensitivity in macaque retina, Mol. Ther., 25, 2546, 10.1016/j.ymthe.2017.07.011 · DOI
- Cronin, 2014, Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter, EMBO Mol. Med., 6, 1175, 10.15252/emmm.201404077 · DOI · Paper page
- Dartnall, 1983, Human visual pigments: microspectrophotometric results from the eyes of seven persons, Proc. R. Soc. Lond. B Biol. Sci., 220, 115, 10.1098/rspb.1983.0091 · DOI · Paper page
- Day, 2014, Advances in AAV vector development for gene therapy in the retina, Adv. Exp. Med. Biol., 801, 687, 10.1007/978-1-4614-3209-8_86 · DOI
- De Silva, 2017, Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapy, Proc. Natl. Acad. Sci. U. S. A., 114, 11211, 10.1073/pnas.1701589114 · DOI · Paper page
- Di Marco, 2009, Permanent functional reorganization of retinal circuits induced by early long-term visual deprivation, J. Neurosci., 29, 13691, 10.1523/JNEUROSCI.3854-09.2009 · DOI
- Do, 2008, Surgery for post-vitrectomy cataract, Cochrane Database Syst. Rev., 10.1002/14651858.CD006366.pub2 · DOI
- Doroudchi, 2011, Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness, Mol. Ther., 19, 1220, 10.1038/mt.2011.69 · DOI · Paper page
- Duebel, 2015, Optogenetics, Curr. Opin. Ophthalmol., 26, 226, 10.1097/ICU.0000000000000140 · DOI
- Gaub, 2015, Optogenetic vision restoration using rhodopsin for enhanced sensitivity, Mol. Ther., 23, 1562, 10.1038/mt.2015.121 · DOI · Paper page
- Grunwald, 1996, Retinal hemodynamics in retinitis pigmentosa, Am. J. Ophthalmol., 122, 502, 10.1016/S0002-9394(14)72109-9 · DOI · Paper page
- Ham, 1984, Basic mechanisms underlying the production of photochemical lesions in the mammalian retina, Curr. Eye Res., 3, 165, 10.3109/02713688408997198 · DOI · Paper page
- Hood, 1993, Human cone receptor activity: the leading edge of the a-wave and models of receptor activity, Vis. Neurosci., 10, 857, 10.1017/S0952523800006076 · DOI · Paper page
- Hood, 1993, Light adaptation of human rod receptors: the leading edge of the human a-wave and models of rod receptor activity, Vis. Res., 33, 1605, 10.1016/0042-6989(93)90027-T · DOI · Paper page
- Hughes, 2016, Signalling by melanopsin (OPN4) expressing photosensitive retinal ganglion cells, Eye, 30, 247, 10.1038/eye.2015.264 · DOI
- Jacobson, 2013, Retinal optogenetic therapies: clinical criteria for candidacy, Clin. Genet., 84, 175, 10.1111/cge.12165 · DOI
- Jones, 2016, Retinal remodeling in human retinitis pigmentosa, Exp. Eye Res., 150, 149, 10.1016/j.exer.2016.03.018 · DOI · Paper page
- Kleinlogel, 2011, Ultra light-sensitive and fast neuronal activation with the Ca(2)+-permeable channelrhodopsin CatCh, Nat. Neurosci., 14, 513, 10.1038/nn.2776 · DOI · Paper page
- Lagali, 2008, Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration, Nat. Neurosci., 11, 667, 10.1038/nn.2117 · DOI · Paper page
- Leveillard, 2004, Identification and characterization of rod-derived cone viability factor, Nat. Genet., 36, 755, 10.1038/ng1386 · DOI · Paper page
- Liew, 2014, A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010, BMJ Open, 4, 10.1136/bmjopen-2013-004015 · DOI · Paper page
- Lin, 2008, Restoration of visual function in retinal degeneration mice by ectopic expression of melanopsin, Proc. Natl. Acad. Sci. U. S. A., 105, 16009, 10.1073/pnas.0806114105 · DOI · Paper page
- Lin, 2011, A user's guide to channelrhodopsin variants: features, limitations and future developments, Exp. Physiol., 96, 19, 10.1113/expphysiol.2009.051961 · DOI · Paper page
- Liu, 2016, Human melanopsin-AAV2/8 transfection to retina transiently restores visual function in rd1 mice, Int. J. Ophthalmol., 9, 655
- Mace, 2015, Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice, Mol. Ther., 23, 7, 10.1038/mt.2014.154 · DOI · Paper page
- Masland, 2012, The neuronal organization of the retina, Neuron, 76, 266, 10.1016/j.neuron.2012.10.002 · DOI · Paper page
- Mollon, 1989, “Tho' she kneel'd in that place where they grew...” the uses and origins of primate colour vision, J. Exp. Biol., 146, 21, 10.1242/jeb.146.1.21 · DOI · Paper page
- Mollon, 1998, What is the function of the cone-rich rim of the retina?, Eye, 12, 548, 10.1038/eye.1998.144 · DOI
- Moore, 2017, Genetic testing for inherited retinal disease, Ophthalmology, 124, 1254, 10.1016/j.ophtha.2017.06.018 · DOI
- Ochakovski, 2017, Retinal gene therapy: surgical vector delivery in the translation to clinical trials, Front. Neurosci., 11, 174, 10.3389/fnins.2017.00174 · DOI · Paper page
- Osorio, 2004, Visual pigments: trading noise for fast recovery, Curr. Biol., 14, R1051, 10.1016/j.cub.2004.11.044 · DOI
- Patricio, 2017, Inclusion of the Woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2-driven transduction of mouse and human retina, Mol. Ther. Nucleic Acids, 6, 198, 10.1016/j.omtn.2016.12.006 · DOI · Paper page
- Russell, 2017, Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial, Lancet, 390, 849, 10.1016/S0140-6736(17)31868-8 · DOI · Paper page
- Sato, 2017, Visual responses of photoreceptor-degenerated rats expressing two different types of channelrhodopsin genes, Sci. Rep., 7, 41210, 10.1038/srep41210 · DOI
- Schiller, 1986, Functions of the ON and OFF channels of the visual system, Nature, 322, 824, 10.1038/322824a0 · DOI · Paper page
- Semo, 2003, Melanopsin retinal ganglion cells and the maintenance of circadian and pupillary responses to light in aged rodless/coneless (rd/rd cl) mice, Eur. J. Neurosci., 17, 1793, 10.1046/j.1460-9568.2003.02616.x · DOI · Paper page
- Sengupta, 2016, Red-shifted channelrhodopsin stimulation restores light responses in blind mice, macaque retina, and human retina, EMBO Mol. Med., 8, 1248, 10.15252/emmm.201505699 · DOI · Paper page
- Sharpe, 2005, A luminous efficiency function, V*(lambda), for daylight adaptation, J. Vis., 5, 948, 10.1167/5.11.3 · DOI · Paper page
- Silveira, 1999, Ganglion cells of a short-wavelength-sensitive cone pathway in New World monkeys: morphology and physiology, Vis. Neurosci., 16, 333, 10.1017/S0952523899162138 · DOI
- Simunovic, 1998, The cone dystrophies, Eye, 12, 553, 10.1038/eye.1998.145 · DOI
- Simunovic, 2017, Structural and functional recovery following limited iatrogenic macular detachment for retinal gene therapy, JAMA Ophthalmol, 135, 234, 10.1001/jamaophthalmol.2016.5630 · DOI · Paper page
- Stabell, 1996, Peripheral colour vision: effects of rod intrusion at different eccentricities, Vis. Res., 36, 3407, 10.1016/0042-6989(96)00079-X · doi:10.1016/0042-6989(96)00079-x
- Thyagarajan, 2010, Visual function in mice with photoreceptor degeneration and transgenic expression of channelrhodopsin 2 in ganglion cells, J. Neurosci., 30, 8745, 10.1523/JNEUROSCI.4417-09.2010 · DOI · Paper page
- Tomita, 2010, Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats, Exp. Eye Res., 90, 429, 10.1016/j.exer.2009.12.006 · DOI · Paper page
- Tomita, 2014, Restoration of the majority of the visual spectrum by using modified Volvox channelrhodopsin-1, Mol. Ther., 22, 1434, 10.1038/mt.2014.81 · DOI
- Tomita, 2007, Restoration of visual response in aged dystrophic RCS rats using AAV-mediated channelopsin-2 gene transfer, Invest. Ophthalmol. Vis. Sci., 48, 3821, 10.1167/iovs.06-1501 · DOI · Paper page
- van Wyk, 2015, Restoring the ON switch in blind retinas: opto-mGluR6, a next-generation, cell-tailored optogenetic tool, PLoS Biol., 13, 10.1371/journal.pbio.1002143 · DOI · Paper page
- von Noorden, 1978, Application of basic research data to clinical amblyopia, Ophthalmology, 85, 496, 10.1016/S0161-6420(78)35652-9 · doi:10.1016/s0161-6420(78)35652-9
- Wright, 1997, A searchlight through the fog, Nat. Genet., 17, 132, 10.1038/ng1097-132 · DOI
- Zeng, 2017, Neuronal cell-type classification: challenges, opportunities and the path forward, Nat. Rev. Neurosci., 18, 530, 10.1038/nrn.2017.85 · DOI · Paper page
- Zhang, 2009, Ectopic expression of multiple microbial rhodopsins restores ON and OFF light responses in retinas with photoreceptor degeneration, J. Neurosci., 29, 9186, 10.1523/JNEUROSCI.0184-09.2009 · DOI · Paper page
Cited by
Molecular Therapies for Inherited Retinal Diseases—Current Standing, Opportunities and Challenges
Vázquez-Domínguez, I., Garanto, A., & Collin, R. W. J. (2019) · Genes · doi:10.3390/genes10090654 · Cited by 80
Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses
Ghoraba, H. H., Akhavanrezayat, A., Karaca, I., Yavari, N., Lajevardi, S., Hwang, J., Regenold, J., Matsumiya, W., Pham, B., Zaidi, M., et al. (2022) · Clinical Ophthalmology · doi:10.2147/opth.s364200 · Cited by 76
“This approach has the potential to improve visual perception in cases of RP and other inherited retinal diseases where the photoreceptors are severely damaged.(50) Usher syndrome displays AR inheritance with different large-sized causative genes, including MYO7A, USH2A and GPR98.”
BackgroundUpdate on viral gene therapy clinical trials for retinal diseases
Cheng, S.-Y., & Punzo, C. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.159 · Cited by 49
Advances in ophthalmic optogenetics: approaches and applications
Prosseda, P. P., Tran, M., Kowal, T., Wang, B., & Sun, Y. (2022) · Biomolecules · doi:10.3390/biom12020269 · Cited by 41
The argus ii retinal prosthesis system
Bloch, E., & da Cruz, L. (2020) · Prosthesis · doi:10.5772/intechopen.84947 · Cited by 31
Metadata
- Authors
- Simunovic, M. P., Shen, W., Lin, J. Y., Protti, D. A., Lisowski, L., & Gillies, M. C.
- Venue
- Experimental Eye Research
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 178
- Pages
- 15-26
- ISSN
- 0014-4835 (ISSN-L)
- OpenAlex
- W2890167217
- Cited by
- 109
- References
- 14
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Foundation Fighting Blindness USA
- Career Development Award (CD-CL-0816-0710-SYD)
- Sydney Medical School Foundation (RY502)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optogenetic approaches to vision restoration. https://app.cochat.ai/papers/10.1016/j.exer.2018.09.003
- The paper
- Simunovic, M. P., Shen, W., Lin, J. Y., Protti, D. A., Lisowski, L., & Gillies, M. C. (2019). Optogenetic approaches to vision restoration. Experimental Eye Research. https://doi.org/10.1016/j.exer.2018.09.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.